InvestorsHub Logo
Followers 12
Posts 917
Boards Moderated 0
Alias Born 08/01/2006

Re: None

Thursday, 02/07/2013 8:14:06 AM

Thursday, February 07, 2013 8:14:06 AM

Post# of 687465
Lack of transparency and communications has been a problem with this company in the past. They have not been forthcoming with enrollment data and it took them a very long time to get their manufacturing established. That may be the reason things have progressed so slowly to this point. I also read an article awhile back that indicated that their manufacturing process was more complex and expensive that IMUC's, which was also postulated to be slowing things down.

This company is still in the lead in the GBM vaccine race, at least on paper. It remains a question for the company to prove that is true in execution. For now I'm riding the IMUC surge and watching here.

I'll see if I can dig up the article I mentioned and post it.


GLTA,

Murocman
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News